Results 91 to 100 of about 35,539 (289)

Rubella Antibody Levels in School-Aged Children in Newfoundland: Implications for a Two-Dose Rubella Vaccination Strategy

open access: yesCanadian Journal of Infectious Diseases, 1997
OBJECTIVE: To determine the prevailing levels of rubella immunity among school-aged children who received a single dose of measles-mumps-rubella (MMR) vaccine at one year of age.
Samuel Ratnam   +4 more
doaj   +1 more source

No demonstrable association between the Leningrad–Zagreb mumps vaccine strain and aseptic meningitis in a large clinical trial in Egypt [PDF]

open access: yes, 2010
To address the claim that the Leningrad–Zagreb (L-Z) mumps vaccine strain is causally associated with aseptic meningitis, a prospective, post-marketing safety study was conducted with a measles-mumps-rubella vaccine (MMR) (TRESIVAC°; Serum Institute of ...
Abou Bakr, S.S.   +6 more
core   +1 more source

Childhood Vaccine Hesitancy as an Interaction‐Based Phenomenon

open access: yesSociology of Health &Illness, Volume 47, Issue 4, May 2025.
ABSTRACT The paper discusses the role of the interaction between parents and healthcare professionals in overcoming or heightening childhood vaccine hesitancy. Childhood vaccine hesitancy is seen as a set of attitudes and behaviours—that is, dispositions—that are highly dependent on how trust and vulnerability intersect during vaccination appointments.
Alice Scavarda   +2 more
wiley   +1 more source

Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study

open access: yesDermatologic Therapy, 2015
Intralesional purified protein derivative (PPD) or mumps, measles, rubella (MMR) were not previously compared regarding their efficacy or mechanism of action in treatment of warts.
M. Shaheen   +3 more
semanticscholar   +1 more source

Deep sequencing reveals persistence of cell-associated mumps vaccine virus in chronic encephalitis. [PDF]

open access: yes, 2016
Routine childhood vaccination against measles, mumps and rubella has virtually abolished virus-related morbidity and mortality. Notwithstanding this, we describe here devastating neurological complications associated with the detection of live-attenuated
Breuer, J   +20 more
core   +2 more sources

Protocol for a feasibility and acceptability study for UK general population paediatric type 1 diabetes screening—the EarLy Surveillance for Autoimmune diabetes (ELSA) study

open access: yesDiabetic Medicine, Volume 42, Issue 5, May 2025.
Abstract Aim The EarLy Surveillance for Autoimmune (ELSA) study aims to explore the feasibility and acceptability of UK paediatric general population screening for type 1 diabetes. Methods We aim to screen 20,000 children aged 3–13 years for islet‐specific autoantibodies through dried blood spot sample collection at home, hospital or community settings.
Lauren M. Quinn   +20 more
wiley   +1 more source

Know the facts before you choose [PDF]

open access: yes
There are two options for protecting your child against measles, mumps, rubella, and varicella.Thanks to vaccines that protect against measles, mumps, rubella (German measles) and varicella (chickenpox), most children never have to suffer the misery of ...

core  

Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain [PDF]

open access: yes, 2015
BACKGROUND: Elimination of congenital rubella syndrome depends not only on effective childhood immunization but also on the identification and immunization of rubella susceptible women.
Barreales, Saul   +7 more
core   +1 more source

Risk of Serious Infections in Patients Treated With Biologic or Targeted‐synthetic Disease Modifying Antirheumatic Drugs in Qatar

open access: yesImmunity, Inflammation and Disease, Volume 13, Issue 4, April 2025.
This study investigates the risk of serious infections (SIs) in patients treated with biologic or targeted‐synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) in Qatar. Out of 1092 patients, 86 (7.9%) experienced SIs, with adalimumab and infliximab associated with higher SI rates.
Sreethish Sasi   +12 more
wiley   +1 more source

Combination Measles-Mumps-Rubella-Varicella Vaccine in Healthy Children

open access: yesMedicine, 2015
A combined measles-mumps-rubella-varicella (MMRV) vaccine is expected to facilitate universal immunization against these 4 diseases. This study was undertaken to synthesize current research findings of the immunogenicity and safety of MMRV in healthy ...
Shu-juan Ma   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy